GH.NASDAQGuardant Health, INC
Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
Sentiment:
SEC Form 4 Filing
Director Steve Krognes reported the vesting of restricted stock units and subsequent acquisition of common stock in Guardant Health, Inc.
Summary
- On August 31, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- Specifically, 155 restricted stock units vested, which were then converted into 155 shares of common stock.
- The price per share for the conversion was $0.
- Following the transaction, Krognes directly owns 9,603 shares of common stock and 3,394 restricted stock units.
Sentiment
Score: 5
Explanation: The document simply reports a routine stock transaction related to executive compensation; it doesn't inherently convey positive or negative sentiment.
Stakeholder Impact
- The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| 08/09/2022 | Date of restricted stock unit award grant. |
| 06/30/2023 | 25% of the restricted stock units vested. |
| 08/31/2024 | Date of transaction: Vesting of 155 restricted stock units and acquisition of 155 shares of common stock. |
| 09/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.